GB201815695D0 - Synthetic method - Google Patents

Synthetic method

Info

Publication number
GB201815695D0
GB201815695D0 GBGB1815695.0A GB201815695A GB201815695D0 GB 201815695 D0 GB201815695 D0 GB 201815695D0 GB 201815695 A GB201815695 A GB 201815695A GB 201815695 D0 GB201815695 D0 GB 201815695D0
Authority
GB
United Kingdom
Prior art keywords
synthetic method
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1815695.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mereo Biopharma 1 Ltd
Original Assignee
Mereo Biopharma 1 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mereo Biopharma 1 Ltd filed Critical Mereo Biopharma 1 Ltd
Priority to GBGB1815695.0A priority Critical patent/GB201815695D0/en
Publication of GB201815695D0 publication Critical patent/GB201815695D0/en
Priority to PCT/GB2019/052718 priority patent/WO2020065323A1/en
Priority to CN201980063294.3A priority patent/CN112839928B/zh
Priority to CA3112993A priority patent/CA3112993A1/en
Priority to AU2019350525A priority patent/AU2019350525B2/en
Priority to JP2021516883A priority patent/JP7291782B2/ja
Priority to IL281636A priority patent/IL281636B2/en
Priority to DK19780305.9T priority patent/DK3856721T3/da
Priority to US17/279,553 priority patent/US11649213B2/en
Priority to ES19780305T priority patent/ES2943289T3/es
Priority to EP19780305.9A priority patent/EP3856721B1/en
Priority to KR1020217008904A priority patent/KR102711257B1/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/22Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB1815695.0A 2018-09-26 2018-09-26 Synthetic method Ceased GB201815695D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1815695.0A GB201815695D0 (en) 2018-09-26 2018-09-26 Synthetic method
KR1020217008904A KR102711257B1 (ko) 2018-09-26 2019-09-26 3-[5-아미노-4-(3-시아노벤조일)-피라졸 화합물의 제조를 위한 합성 방법
AU2019350525A AU2019350525B2 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-Amino-4-(3-Cyanobenzoyl)-Pyrazol compound
CN201980063294.3A CN112839928B (zh) 2018-09-26 2019-09-26 用于制备3-[5-氨基-4-(3-氰基苯甲酰基)-吡唑化合物的合成方法
CA3112993A CA3112993A1 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
PCT/GB2019/052718 WO2020065323A1 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
JP2021516883A JP7291782B2 (ja) 2018-09-26 2019-09-26 3-[5-アミノ-4-(3-シアノベンゾイル)-ピラゾール化合物の調製のための合成方法
IL281636A IL281636B2 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-4-methylbenzoic acid, its products and their uses
DK19780305.9T DK3856721T3 (da) 2018-09-26 2019-09-26 Syntetisk fremgangsmåde til fremstillingen af en 3-[5-amino-4-(3-cyanobenzoyl)-pyrazolforbindelse
US17/279,553 US11649213B2 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
ES19780305T ES2943289T3 (es) 2018-09-26 2019-09-26 Método de síntesis para la preparación de un compuesto de 3-[5-amino-4-(3-cianobenzoil)-pirazol
EP19780305.9A EP3856721B1 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1815695.0A GB201815695D0 (en) 2018-09-26 2018-09-26 Synthetic method

Publications (1)

Publication Number Publication Date
GB201815695D0 true GB201815695D0 (en) 2018-11-07

Family

ID=64024269

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1815695.0A Ceased GB201815695D0 (en) 2018-09-26 2018-09-26 Synthetic method

Country Status (12)

Country Link
US (1) US11649213B2 (https=)
EP (1) EP3856721B1 (https=)
JP (1) JP7291782B2 (https=)
KR (1) KR102711257B1 (https=)
CN (1) CN112839928B (https=)
AU (1) AU2019350525B2 (https=)
CA (1) CA3112993A1 (https=)
DK (1) DK3856721T3 (https=)
ES (1) ES2943289T3 (https=)
GB (1) GB201815695D0 (https=)
IL (1) IL281636B2 (https=)
WO (1) WO2020065323A1 (https=)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1809386A1 (de) 1968-11-16 1970-06-11 Bayer Ag Verfahren zur Herstellung von 1,5-disubstituierten 4-Cyanopyrazolen
US4686221A (en) * 1985-10-01 1987-08-11 Kanebo, Ltd. Quinolinecarboxylic acid compounds and antimicrobial agent containing the same
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
US6103900A (en) * 1992-12-17 2000-08-15 Pfizer Inc Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
FR2732967B1 (fr) 1995-04-11 1997-07-04 Sanofi Sa 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
HRP20000724A2 (en) * 1998-05-05 2001-06-30 Hoffmann La Roche Pyrazole derivatives as p-38 map kinase inhibitors
PL2298743T3 (pl) 2003-06-26 2013-02-28 Novartis Ag Inhibitory kinaz P38 na bazie 5-członowych heterocykli
WO2005007632A1 (en) 2003-07-18 2005-01-27 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
US7485657B2 (en) 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
ATE510836T1 (de) 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
AU2008281594A1 (en) 2007-08-02 2009-02-05 Generics [Uk] Limited Novel process
WO2009088025A1 (ja) 2008-01-10 2009-07-16 Hokko Chemical Industry Co., Ltd. フェニルトリアゾリノン類の製造法
JP5602387B2 (ja) 2008-05-02 2014-10-08 キヤノン株式会社 インクジェット用インク、インクジェット記録方法、インクカートリッジ、記録ユニット、及びインクジェット記録装置
CN102964270B (zh) 2012-11-21 2015-01-07 合肥星宇化学有限责任公司 一种亚硫酸钠还原重氮盐合成肼的方法
WO2018059533A1 (zh) 2016-09-29 2018-04-05 南京明德新药研发股份有限公司 p38αMAPK激酶抑制剂及其制备方法和应用

Also Published As

Publication number Publication date
WO2020065323A1 (en) 2020-04-02
CN112839928B (zh) 2024-04-30
KR102711257B1 (ko) 2024-09-30
US20210395207A1 (en) 2021-12-23
JP2022502400A (ja) 2022-01-11
EP3856721A1 (en) 2021-08-04
DK3856721T3 (da) 2023-04-24
US11649213B2 (en) 2023-05-16
EP3856721B1 (en) 2023-03-29
IL281636B2 (en) 2024-08-01
AU2019350525A1 (en) 2021-04-15
CN112839928A (zh) 2021-05-25
AU2019350525B2 (en) 2024-05-02
IL281636B1 (en) 2024-04-01
JP7291782B2 (ja) 2023-06-15
KR20210069044A (ko) 2021-06-10
IL281636A (en) 2021-05-31
CA3112993A1 (en) 2020-04-02
ES2943289T3 (es) 2023-06-12

Similar Documents

Publication Publication Date Title
GB201800298D0 (en) Method
GB201809323D0 (en) Method
GB201807793D0 (en) Method
GB201808554D0 (en) Method
GB201800558D0 (en) Method
GB201811813D0 (en) Method
GB201811811D0 (en) Method
GB201811810D0 (en) Method
GB201805876D0 (en) Method
GB201808663D0 (en) Method
GB201814039D0 (en) Method
GB201803750D0 (en) Method
GB201812603D0 (en) Method
GB201809403D0 (en) Method
GB201804277D0 (en) Method
GB201802744D0 (en) Method
GB201808558D0 (en) Method
GB201807788D0 (en) Method
GB201806240D0 (en) Method
GB201817802D0 (en) Method
GB201804289D0 (en) Method
GB201803183D0 (en) Method
GB201802653D0 (en) Method
GB201800187D0 (en) Method
GB201808556D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)